Illumina appoints Joydeep Goswami as Interim CFO
Sam Samad will be departing Illumina on July 8, 2022, after serving as CFO for more than five years.
Sam Samad will be departing Illumina on July 8, 2022, after serving as CFO for more than five years.
GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones
The company will invest approximately €440 million to increase membrane manufacturing capacity in Carrigtwohill and to build a new manufacturing facility at Blarney Business Park, both in Cork, Ireland
Pioneering Medicines and Novo Nordisk Bio Innovation Hub will leverage Flagship Pioneering’s bioplatform companies to create a portfolio of research programmes within cardiometabolic and rare diseases
Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities
Recognition illustrates Takeda’s patient-centricity throughout its manufacturing and supply processes
RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology-related deals dominate the landscape
This collaboration has resulted in several high-impact scientific publications describing breakthrough inventions, including the SOMA robotic pill, which has subsequently been licensed exclusively to Novo Nordisk for clinical development
Senior R&D leader from Pfizer and bluebird bio to support Strand’s platform of programmable mRNA-based therapeutics
Newly formed Life Science Services business unit to offer fully integrated CDMO and Contract Testing Services
Subscribe To Our Newsletter & Stay Updated